• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Docetaxel for Early Prostate Cancer: What Have We Learned?

作者信息

Beltran Himisha, Morris Michael J

机构信息

Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.

Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Eur Urol. 2020 May;77(5):573-575. doi: 10.1016/j.eururo.2020.01.026. Epub 2020 Feb 7.

DOI:10.1016/j.eururo.2020.01.026
PMID:32037142
Abstract
摘要

相似文献

1
Docetaxel for Early Prostate Cancer: What Have We Learned?多西他赛用于早期前列腺癌：我们学到了什么？
Eur Urol. 2020 May;77(5):573-575. doi: 10.1016/j.eururo.2020.01.026. Epub 2020 Feb 7.
2
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.多西他赛对比根治性前列腺切除术后高危前列腺癌的监测：来自前瞻性随机、开放标签 3 期斯堪的纳维亚前列腺癌组 12 试验的结果。
Eur Urol. 2018 Jun;73(6):870-876. doi: 10.1016/j.eururo.2018.01.012. Epub 2018 Feb 1.
3
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.退伍军人事务部合作研究项目553：前列腺切除术后化疗，一项针对高危局限性前列腺癌患者的前列腺切除术与前列腺切除术联合多西他赛辅助治疗的III期随机研究。
Urology. 2008 Sep;72(3):474-80. doi: 10.1016/j.urology.2008.02.050. Epub 2008 Apr 14.
4
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.癌症与白血病B组（CALGB）90203研究：一项针对高危局限性疾病患者的随机3期研究，比较单纯根治性前列腺切除术与根治性前列腺切除术前行雌莫司汀和多西他赛治疗的疗效。
Urology. 2003 Dec 29;62 Suppl 1:55-62. doi: 10.1016/j.urology.2003.09.052.
5
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates.多西他赛和米托蒽醌用于高危前列腺癌男性患者根治性前列腺切除术之前：10年随访及免疫相关性
Anticancer Drugs. 2017 Jan;28(1):120-126. doi: 10.1097/CAD.0000000000000438.
6
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.高危局限性前列腺癌患者在根治性前列腺切除术前行新辅助多西他赛治疗。
Clin Cancer Res. 2005 Jul 15;11(14):5233-40. doi: 10.1158/1078-0432.CCR-05-0299.
7
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.高危局限性前列腺癌患者前列腺切除术前每周使用米托蒽醌和多西他赛的I期研究。
Clin Cancer Res. 2004 Feb 15;10(4):1306-11. doi: 10.1158/1078-0432.ccr-1021-03.
8
[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].[多西他赛治疗前列腺癌患者的综合足病医生护理：可行性与结果]
Bull Cancer. 2018 Dec;105(12):1173-1182. doi: 10.1016/j.bulcan.2018.06.005. Epub 2018 Aug 2.
9
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.前列腺癌根治术后高危患者辅助使用多西他赛每周治疗：一项多机构试点研究。
J Urol. 2007 May;177(5):1777-81. doi: 10.1016/j.juro.2007.01.028.
10
Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!阿比特龙还是多西他赛用于去势敏感性转移性前列腺癌？这是个问题！
Eur Urol. 2018 Jan;73(1):147-148. doi: 10.1016/j.eururo.2017.07.030. Epub 2017 Aug 8.

引用本文的文献

1
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.多西他赛通过抑制 MDSC 增强了 PSMA 特异性 CAR-T 细胞对前列腺癌模型的治疗效果。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3511-3520. doi: 10.1007/s00432-022-04248-y. Epub 2022 Aug 12.
2
Molecular relation between biological stress and carcinogenesis.生物应激与癌变的分子关系。
Mol Biol Rep. 2022 Oct;49(10):9929-9945. doi: 10.1007/s11033-022-07543-6. Epub 2022 May 24.
3
MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer.
微小 RNA-mRNA 调控网络介导非洲裔美国前列腺癌中 mTOR 和 VEGF 信号的激活。
Int J Mol Sci. 2022 Mar 8;23(6):2926. doi: 10.3390/ijms23062926.
4
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503).高风险生化复发前列腺癌术后雄激素剥夺治疗联合或不联合多西他赛的 3 期随机对照试验（TAX3503）
Eur Urol Oncol. 2021 Aug;4(4):543-552. doi: 10.1016/j.euo.2021.04.008. Epub 2021 May 18.